E-ISSN 2149-388X | ISSN 2149-0430
 
2025, Vol: 11, Issue: 1
11 / 1Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

Cover Letter
License Agreement
Title Page

Meta-Analysis 


Clinical and Microbiological Efficacy of CSE-1034 in Treatment of Acute Bacterial Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Shao-huan Lan, Chien-ming Chao, Shen-peng Chang, Li-chin Lu, Tzu-liang Hsu.


Abstract
This study aimed to conduct a meta-analysis to assess the clinical and microbiological efficacy of CSE-1034 for treating acute bacterial infections in adult patients. PubMed, Embase, ClinicalTrials.gov, and Cochrane databases were searched from their inception until April 2022 for relevant randomized controlled trials (RCTs). Only RCTs evaluating CSE-1034 and comparators for treating acute bacterial infections in adult patients were included. The primary outcome was the clinical response rate at the end of treatment (EOT) evaluation. Five RCTs were included. A total of 950 patients (n:638 in the UTI group, n:186 in the lower respiratory tract infection group, n:70 in the bone and joint infection group, and n:56 in SSSI) were included in this meta-analysis; 478 and 472 patients received CSE-1034 and comparators, respectively. Overall, CSE-1034 had a higher clinical cure rate at EOT than did the comparators (95.3% [384/403] vs. 81% [319/394], RR, 1.2; 95%CI, 1.04-1.39; I2=92%). Moreover, the clinical failure rate of CSE-1034 was lower than that of the comparators (RR, 0.04; 95%CI, 0.01-0.13; I2=0%). CSE-1034 also had a higher microbiological eradication rate than the comparators (92.9% [315/339] vs. 71.1% [216/304], RR, 1.53; 95%CI, 1.06-2.21; I2=97%). The clinical and microbiological efficacy of CSE-1034 is comparable or even superior in treating acute bacterial infections.

Key words: CSE-1034, acute bacterial infection, urinary tract infection, lower respiratory tract infection, community-acquired bacterial pneumonia


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Shao-Huan Lan
Articles by Chien-Ming Chao
Articles by Shen-Peng Chang
Articles by Li-Chin Lu
Articles by Tzu-Liang Hsu
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Lan S, Chao C, Chang S, Lu L, Hsu T. Clinical and Microbiological Efficacy of CSE-1034 in Treatment of Acute Bacterial Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Ulutas Med J. 2022; 8(4): 118-126. doi:10.5455/umj.20220622065911

Web Style

Lan S, Chao C, Chang S, Lu L, Hsu T. Clinical and Microbiological Efficacy of CSE-1034 in Treatment of Acute Bacterial Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. https://www.ulutasmedicaljournal.com/?mno=65602 [Access: March 15, 2025]. doi:10.5455/umj.20220622065911

AMA (American Medical Association) Style

Lan S, Chao C, Chang S, Lu L, Hsu T. Clinical and Microbiological Efficacy of CSE-1034 in Treatment of Acute Bacterial Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Ulutas Med J. 2022; 8(4): 118-126. doi:10.5455/umj.20220622065911


Vancouver/ICMJE Style

Lan S, Chao C, Chang S, Lu L, Hsu T. Clinical and Microbiological Efficacy of CSE-1034 in Treatment of Acute Bacterial Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Ulutas Med J. (2022), [cited March 15, 2025]; 8(4): 118-126. doi:10.5455/umj.20220622065911


Harvard Style

Lan, S., Chao, . C., Chang, . S., Lu, . L. & Hsu, . T. (2022) Clinical and Microbiological Efficacy of CSE-1034 in Treatment of Acute Bacterial Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Ulutas Med J, 8 (4), 118-126. doi:10.5455/umj.20220622065911


Turabian Style

Lan, Shao-huan, Chien-ming Chao, Shen-peng Chang, Li-chin Lu, and Tzu-liang Hsu. 2022. Clinical and Microbiological Efficacy of CSE-1034 in Treatment of Acute Bacterial Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. THE ULUTAS MEDICAL JOURNAL, 8 (4), 118-126. doi:10.5455/umj.20220622065911


Chicago Style

Lan, Shao-huan, Chien-ming Chao, Shen-peng Chang, Li-chin Lu, and Tzu-liang Hsu. "Clinical and Microbiological Efficacy of CSE-1034 in Treatment of Acute Bacterial Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials." THE ULUTAS MEDICAL JOURNAL 8 (2022), 118-126. doi:10.5455/umj.20220622065911


MLA (The Modern Language Association) Style

Lan, Shao-huan, Chien-ming Chao, Shen-peng Chang, Li-chin Lu, and Tzu-liang Hsu. "Clinical and Microbiological Efficacy of CSE-1034 in Treatment of Acute Bacterial Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials." THE ULUTAS MEDICAL JOURNAL 8.4 (2022), 118-126. Print. doi:10.5455/umj.20220622065911


APA (American Psychological Association) Style

Lan, S., Chao, . C., Chang, . S., Lu, . L. & Hsu, . T. (2022) Clinical and Microbiological Efficacy of CSE-1034 in Treatment of Acute Bacterial Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. THE ULUTAS MEDICAL JOURNAL, 8 (4), 118-126. doi:10.5455/umj.20220622065911


Author LoginReviewer LoginAbout PublisherOpen Access PolicyEditorial PoliciesEditorial Review PolicyPeer Review PolicyEditorial & Peer Review ProcessAuthor's Rights and ObligationsPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Privacy PolicyCorrections, Retractions & Expressions of ConcernSelf-Archiving PoliciesDigital Archiving & Preservation PoliciesStatement of Informed ConsentAdvertising PolicyTerms of UseLicense InformationCopyright Information

About THE ULUTAS MEDICAL JOURNAL

The Ulutas Medical Journal (UMJ) is a 3 monthly (quarterly), open access, double-blind peer-reviewed, an international journal. Writing a research pap ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information


Journal Owner
HAYRİYE ZEHRA ULUTAŞ
Phone: +90 (532) 165 96 39​
E-mail: zehrakenanoglu@hotmail.com​
Address: Alaattin Mah. 30. Ada sok. D11 Blok
No:4 Gungor Uydukent Sitesi  Antakya/HATAY

Editor-In-Chief
KEMAL TURKER ULUTAS, MD, Assc. Prof.
Phone: + 90 (555) 491 35 59​
E-mail: drkemalturker@gmail.com
Address: Alaattin Mah. 30. Ada sok. D11 Blok
No:4 Gungor Uydukent Sitesi  Antakya/HATAY

Publisher Information
SCOPEMED Publishing Co. - TURKEY​
E-mail: scopemed@scopemed.org
Web: https://www.scopemed.com/

 

We welcome your submissions, suggestions, comments, or questions. To reach us, please use one of the methods provided on this page or Email us at ulutasmedicaljournal@gmail.com​

We will respond within 48 to 72 hours.